|
Nov 16
|
J&J settles first talc cases to go to trial after failed bankruptcies
|
|
Nov 16
|
10 States With The Most Doctors Per Capita In 2023
|
|
Nov 16
|
Johnson & Johnson (JNJ) Down 2.6% Since Last Earnings Report: Can It Rebound?
|
|
Nov 16
|
Johnson & Johnson to Host Enterprise Business Review
|
|
Nov 16
|
Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On
|
|
Nov 15
|
15 Developed Countries with Lowest Autism Rates
|
|
Nov 15
|
12 Monthly Dividend Stocks with Over 5% Yield
|
|
Nov 15
|
2 Dividend Stocks Near Their 52-Week Lows to Buy and Hold Forever
|
|
Nov 15
|
Berkshire Hathaway exits GM, Johnson & Johnson positions
|
|
Nov 14
|
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, J&J and AbbVie
|
|
Nov 14
|
3 Dividend Giants to Grow Wealth no Matter What the Market Is Doing
|
|
Nov 13
|
Ray Dalio's Bridgewater Associates Adjusts Portfolio, Notably Reduces Johnson & Johnson Stake
|
|
Nov 13
|
Dividend Kings Ranked By Yield: Top 25
|
|
Nov 13
|
4 Large Drug Stocks Likely to Sail Through Industry Woes
|
|
Nov 11
|
Cautious Investor? 2 Safe Stocks You Also Can Count on For Growth
|
|
Nov 10
|
13 Best DRIP Stocks To Own
|
|
Nov 10
|
12 Dogs of the Dow Dividend Stocks to Buy
|
|
Nov 8
|
3 Brilliant Artificial Intelligence Stocks to Buy and Hold Forever
|
|
Nov 7
|
J&J targets 2024 for Ottava FDA filing
|
|
Nov 7
|
2 Magnificent Dividend Stocks Trading Near 52-Week Lows to Buy Now and Hold at Least a Decade
|